Venous thromboembolism can occur in up to 84% of cases following total joint replacement. It can result in pain, swelling, chronic post-thrombotic syndrome, and pulmonary embolism. Its prevention is vital to the success of the surgery. To achieve a safe and effective prophylaxis, a combination of mechanical and pharmacologic agents should be used. New generation of thromboprophylactic agents target different factors of the coagulation pathway.
WarwickDWilliamsMHBannisterGC. Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg Br1995;77:6–10.
2.
WellsPSHirshJAndersonDRLensingAWFosterGKearonC. Accuracy of clinical assessment of deep-vein thrombosis. Lancet1995;345:1326–30.
3.
AnandSSWellsPSHuntDBrill-EdwardsPCookDGinsbergJS. Does this patient have deep vein thrombosis?JAMA1998;279:1094–9.
4.
O'DonnellTFJrAbbottWMAthanasoulisCAMillanVGCallowAD. Diagnosis of deep venous thrombosis in the outpatient by venography. Surg Gynecol Obstet1980;150:69–74.
5.
BarbaRDi MiccoPBlanco-MolinaADelgadoCCisnerosEVillaltaJ. Fever and deep venous thrombosis. Findings from the RIETE registry. J Thromb Thrombolysis2011;32:288–92.
6.
RabinovKPaulinS. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg1972;104:134–44.
7.
LeutzDWStaufferES. Color duplex Doppler ultrasound scanning for detection of deep venous thrombosis in total knee and hip arthroplasty patients. Incidence, location, and diagnostic accuracy compared with ascending venography. J Arthroplasty1994;9:543–8.
8.
AndersonFAJrWheelerHBGoldbergRJHosmerDWPatwardhanNAJovanovicB. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med1991;151:933–8.
9.
SteinPDAthanasoulisCAlaviAGreenspanRHHalesCASaltzmanHA. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation1992;85:462–8.
10.
MinichielloTFogartyPF. Diagnosis and management of venous thromboembolism. Med Clin North Am2008;92:443–65.
11.
AndersonDRKahnSRRodgerMAKovacsMJMorrisTHirschA. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: A randomized controlled trial. JAMA2007;298:2743–53.
FreedmanKBBrookenthalKRFitzgeraldRHJrWilliamsSLonnerJH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am2000;82:929–38.
14.
BrookenthalKRFreedmanKBLotkePAFitzgeraldRHLonnerJH. A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty2001;16:293–300.
15.
HowieCHughesHWattsAC. Venous thromboembolism associated with hip and knee replacement over a ten-year period: A population-based study. J Bone Joint Surg Br2005;87:1675–80.
16.
JunZJPingTLeiYLiLMingSYJingW. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol2006;28:111–6.
17.
ReesDCCoxMCleggJB. World distribution of factor V Leiden. Lancet1995;346:1133–4.
18.
KanchanabatBStapanavatrWMeknavinSSoorapanthCSumanasrethakulCKanchanasuttirakP. Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis. Br J Surg2011;98:1356–64.
19.
LeizoroviczA; SMART Venography Study Steering Committee. Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography study. Haematologica2007;92:1194–200.
20.
FujiTFujitaSOchiT. Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients. Int Orthop2008;32:443–51.
21.
KimYHKimJS. Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br2002;84:566–70.
22.
RobertsLNPatelRKAryaR. Venous thromboembolism and ethnicity. Br J Haematol2009;146:369–83.
23.
AckerknechtEHVirchowR. Doctor, statesman, anthropologist. Madison: University of Wisconsin Press; 1953.
24.
McNallyMAMollanRA. Total hip replacement, lower limb blood flow and venous thrombogenesis. J Bone Joint Surg Br1993;75:640–4.
25.
SikorskiJMHampsonWGStaddonGE. The natural history and aetiology of deep vein thrombosis after total hip replacement. J Bone Joint Surg Br1981;63:171–7.
26.
PedersenABSorensenHTMehnertFOvergaardSJohnsenSP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am2010;92:2156–64.
27.
KyrlePAEichingerS. Deep vein thrombosis. Lancet2005;365:1163–74.
28.
CampbellIABentleyDPPrescottRJRoutledgePAShettyHGWilliamsonIJ. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: Randomised trial. BMJ2007;334:674.
29.
BoutitieFPinedeLSchulmanS. Incidence of recurrent venous thromboembolism according to duration of vitamin K antagonism. Blood2004;104:a710. [not found]
30.
KearonCKahnSRAgnelliGGoldhaberSRaskobGEComerotaAJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest2008;133(6 Suppl):454S–545S.
31.
British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax2003;58:470–83.
32.
ErikssonBIKakkarAKTurpieAGGentMBandelTJHomeringM. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement. J Bone Joint Surg Br2009;91:636–44.
33.
CohenAT; Asia-Pacific Thrombosis Advisory Board. Asia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery. Thromb Haemost2010;104:919–30.
34.
JohansonNALachiewiczPFLiebermanJRLotkePAParviziJPellegriniV. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg2009;17:183–96.
35.
GeertsWHPineoGFHeitJABergqvistDLassenMRColwellCW. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest2004;126(3 Suppl):338S–400S.
36.
GuyattGHAklEACrowtherMGuttermanDDSchuünemannHJ; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest2012;141(2 Suppl):7S–47S.
37.
MontMAJacobsJJBoggioLNBozicKJDella ValleCJGoodmanSB. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg2011;19:768–76.
38.
WestrichGHSpechtLMSharrockNEWindsorRESculcoTPHaasSB. Venous haemodynamics after total knee arthroplasty: Evaluation of active dorsal to plantar flexion and several mechanical compression devices. J Bone Joint Surg Br1998;80:1057–66.
39.
ElsnerASchifferGJubelAKoebkeJAndermahrJ. The venous pump of the first metatarsophalangeal joint: Clinical implications. Foot Ankle Int2007;28:902–9.
40.
AllenbyFBoardmanLPflugJJCalnanJS. Effects of external pneumatic intermittent compression on fibrinolysis in man. Lancet1973;2:1412–4.
41.
MohrDNSilversteinMDMurtaughPAHarrisonJM. Prophylactic agents for venous thrombosis in elective hip surgery. Meta-analysis of studies using venographic assessment. Arch Intern Med1993;153:2221–8.
42.
ClagettGPAndersonFAJrLevineMNSalzmanEWWheelerHB. Prevention of venous thromboembolism. Chest1992;102(4 Suppl):391S–407S.
43.
WestrichGHHaasSBMoscaPPetersonM. Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty. J Bone Joint Surg Br2000;82:795–800.
44.
PittoRPHamerHHeiss-DunlopWKuehleJ. Mechanical prophylaxis of deep-vein thrombosis after total hip replacement: A randomised clinical trial. J Bone Joint Surg Br2004;86:639–42.
45.
WarwickDHarrisonJGlewDMitchelmoreAPetersTJDonovanJ. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial. J Bone Joint Surg Am1998;80:1158–66.
46.
SantoriFSVitulloAStopponiMSantoriNGheraS. Prophylaxis against deep-vein thrombosis in total hip replacement. Comparison of heparin and foot impulse pump. J Bone Joint Surg Br1994;76:579–83.
47.
GelferYTavorHOronAPeerAHalperinNRobinsonD. Deep vein thrombosis prevention in joint arthroplasties: Continuous enhanced circulation therapy vs low molecular weight heparin. J Arthroplasty2006;21:206–14.
48.
LachmannEARookJLTunkelRNaglerW. Complications associated with intermittent pneumatic compression. Arch Phys Med Rehabil1992;73:482–5.
49.
McGroryBJBurkeDW. Peroneal nerve palsy following intermittent sequential pneumatic compression. Orthopedics2000;23:1103–5.
50.
WestrichGHJhonPHSanchezPM. Compliance in using a pneumatic compression device after total knee arthroplasty. Am J Orthop (Belle Mead NJ)2003;32:135–40.
51.
PittoRPYoungS. Foot pumps without graduated compression stockings for prevention of deep-vein thrombosis in total joint replacement: Efficacy, safety and patient compliance. A comparative, prospective clinical trial. Int Orthop2008;32:331–6.
52.
TincklerTF. Absence of pulmonary embolism in Asians?BMJ1964;5381:502. [not found]
53.
SrivastavaSC. Absence of pulmonary embolism in Asians. BMJ1964;5385:772. [not found]
54.
ChanCWHoaglundFT. Pulmonary thromboembolism and venous thrombosis in the Chinese. Clin Orthop Relat Res1980;150:253–60.
55.
MokCKHoaglundFTRogoffSMChowSPMaAYauAC. The incidence of deep vein thrombosis in Hong Kong Chinese after hip surgery for fracture of the proximal femur. Br J Surg1979;66:640–2.
56.
ChanPKChiuKYNgFYYanCH. Pulmonary embolism after total knee arthroplasty: 11-year retrospective review. Presented at the Annual Congress of the Hong Kong Orthopaedic Association; 19–20 Nov 2011; Hong Kong.
57.
YokoteRMatsubaraMHirasawaNHagioSIshiiKTakataC. Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?J Bone Joint Surg Br2011;93:251–6.
58.
SuganoNMikiHNakamuraNAiharaMYamamotoKOhzonoK. Clinical efficacy of mechanical thromboprophylaxis without anticoagulant drugs for elective hip surgery in an Asian population. J Arthroplasty2009;24:1254–7.
59.
WarwickDFriedmanRJAgnelliGGil-GarayEJohnsonKFitzGeraldG. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: Findings from the Global Orthopaedic Registry. J Bone Joint Surg Br2007;89:799–807.
60.
Wille-JorgensenPJorgensenLNCrawfordM. Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome. A systematic review and meta-analysis. Thromb Haemost2005;93:236–41.
61.
PatronoCCollerBFitzGeraldGAHirshJRothG. Platelet-active drugs: The relationships among dose, effectiveness, and side effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest2004;126(3 Suppl):234S–264S.
62.
KhatodMInacioMCBiniSAPaxtonEW. Prophylaxis against pulmonary embolism in patients undergoing total hip arthroplasty. J Bone Joint Surg Am2011;93:1767–72.
63.
KarthikeyanGEikelboomJWTurpieAGHirshJ. Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?Br J Haematol2009;146:142–9.
64.
JamesonSSCharmanSCGreggPJReedMRvan der MeulenJH. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: A non-randomised comparison from information in the National Joint Registry. J Bone Joint Surg Br2011;93:1465–70.
65.
WestrichGHBottnerFWindsorRELaskinRSHaasSBSculcoTP. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. J Arthroplasty2006;21(6Supp 2):139–43.
66.
LotkePAPalevskyHKeenanAMMeranzeSSteinbergMEEckerML. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop Relat Res1996;324:251–8.
67.
LotkePALonnerJH. The benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty. Clin Orthop Relat Res2006;452:175–80.
68.
RyanMGWestrichGHPotterHGSharrockNMaunLMMacaulayW. Effect of mechanical compression on the prevalence of proximal deep venous thrombosis as assessed by magnetic resonance venography. J Bone Joint Surg Am2002;84:1998–2004.
69.
LachiewiczPFKelleySSHadenLR. Two mechanical devices for prophylaxis of thromboembolism after total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br2004;86:1137–41.
70.
WestrichGHSculcoTP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg Am1996;78:826–34.
71.
MontMAJacobsJJ. AAOS clinical practice guideline: Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg2011;19:777–8.
72.
EikelboomJWHirshJSpencerFABaglinTPWeitzJI. Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest2012:141(2 Suppl):e89S–119S.
73.
AnsellJHirshJPollerLBusseyHJacobsonAHylekE. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest2004;126(3 Suppl):204S–233S.
74.
CoventryMBNolanDRBeckenbaughRD. “Delayed” prophylactic anticoagulation: A study of results and complications in 2,012 total hip arthroplasties. J Bone Joint Surg Am1973;55:1487–92.
75.
JohnsonRGreenJRCharnleyJ. Pulmonary embolism and its prophylaxis following the Charnley total hip replacement. Clin Orthop Relat Res1977;127:123–32.
76.
FordyceMJBakerASStaddonGE. Efficacy of fixed minidose warfarin prophylaxis in total hip replacement. BMJ1991;303:219–20.
77.
DaleCGallusAWycherleyALangloisSHowieD. Prevention of venous thrombosis with minidose warfarin after joint replacement. BMJ1991;303:224.
78.
KearonCGinsbergJSKovacsMJAndersonDRWellsPJulianJA. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med2003;349:631–9.
79.
KeeneyJAClohisyJCCurryMCMaloneyWJ. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty. J Arthroplasty2006;21:469–75.
80.
BernMDeshmukhRVNelsonRBierbaumBSevierNHowieN. Low-dose warfarin coupled with lower leg compression is effective prophylaxis against thromboembolic disease after hip arthroplasty. J Arthroplasty2007;22:644–50.
81.
WarwickDDahlOEFisherWD; International Surgical Thrombosis Forum. Orthopaedic thromboprophylaxis: Limitations of current guidelines. J Bone Joint Surg Br2008;90:127–32.
82.
PatelVPWalshMSehgalBPrestonCDeWalHDi CesarePE. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am2007;89:33–8.
83.
ParviziJGhanemEJoshiASharkeyPFHozackWJRothmanRH. Does “excessive” anticoagulation predispose to periprosthetic infection?J Arthroplasty2007;22(6Suppl 2):24–8.
84.
HirshJRaschkeR. Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest2004;126(3 Suppl):188S–203S.
85.
ColwellCWJrCollisDKPaulsonRMcCutchenJWBiglerGTLutzS. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am1999;81:932–40.
86.
FitzgeraldRHJrSpiroTETrowbridgeAAGardinerGAJrWhitsettTLO'ConnellMB. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am2001;83:900–6.
87.
BurnettRSClohisyJCWrightRWMcDonaldDJShivelyRAGivensSA. Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty2007;22:317–24.
88.
JamesonSSBottleAMalviyaAMullerSDReedMR. The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb. J Bone Joint Surg Br2010;92:123–9.
89.
WestrichGH. The role of mechanical and other adjuncts. Am J Knee Surg1999;12:64–71.
90.
DorrLDGendelmanVMaheshwariAVBoutaryMWanZLongWT. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. J Bone Joint Surg Am2007;89:2648–57.
91.
IshibeMKariyaS. Deep venous thrombosis after mini-posterior total hip arthroplasty in Japanese patients. Hip Int2011;21:684–7.
92.
ColwellCWJrBerkowitzSDLiebermanJRCompPCGinsbergJSPaiementG. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am2005;87:2169–77.
93.
ErikssonBIDahlOERosencherNKurthAAvan DijkCNFrostickSP. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: A randomised, double-blind, non-inferiority trial. Lancet2007;370:949–56.
94.
ErikssonBIDahlOERosencherNKurthAAvan DijkCNFrostickSP. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: The RE-MODEL randomized trial. J Thromb Haemost2007;5:2178–85.
95.
WolowaczSERoskellNSPlumbJMCapriniJAErikssonBI. Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis. Thromb Haemost2009;101:77–85.
96.
ErikssonBIDahlOEBullerHRHettiarachchiRRosencherNBravoML. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: The BISTRO II randomized trial. J Thromb Haemost2005;3:103–11.
97.
FujiTFuijitaSUjihiraTSatoT. Dabigatran etexilate prevents venous thromboembolism after total knee arthroplasty in Japanese patients with a safety profile comparable to placebo. J Arthroplasty2010;25:1267–74.
98.
StangierJErikssonBIDahlOEAhnfeltLNehmizGStahleH. Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement. J Clin Pharmacol2005;45:555–63.
99.
FreyburgerGMacouillardGLabroucheSSztarkF. Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: Two observational studies in patients undergoing total hip or total knee replacement. Thromb Res2011;127:457–65.
100.
LiesenfeldKHSchaferHGTroconizIFTillmannCErikssonBIStangierJ. Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: A population model analysis. Br J Clin Pharmacol2006;62:527–37.
101.
RosencherNAlbaladejoP. A new approach with anticoagulant development: Tailoring anticoagulant therapy with dabigatran etexilate according to patient risk. Expert Opin Pharmacother2012;13:217–26.
102.
GalanisTThomsonLPalladinoMMerliGJ. New oral anticoagulants. J Thromb Thrombolysis2011;31:310–20.
103.
AlvesCBatel-MarquesFMacedoAF. Apixaban and rivaroxaban safety after hip and knee arthroplasty: A meta-analysis. J Cardiovasc Pharmacol Ther2012;17:266–76.
104.
JensenCDStevalAPartingtonPFReedMRMullerSD. Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: A retrospective cohort study. J Bone Joint Surg Br2011;93:91–5.
105.
BjornaraBTGudmundsenTEDahlOE. Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg Br2006;88:386–91.
106.
FriedmanRJ. Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty. J Am Acad Orthop Surg2007;15:148–55.
107.
HaasSBBarrackRLWestrichGLachiewiczPF. Venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am2008;90:2764–80.
108.
ColwellCWJrFroimsonMIMontMARitterMATrousdaleRTBuehlerKC. Thrombosis prevention after total hip arthroplasty: A prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin. J Bone Joint Surg Am2010;92:527–35.
109.
Della ValleA GonzalezSerotaAGoGSorriauxGSculcoTPSharrockNE. Venous thromboembolism is rare with a multimodal prophylaxis protocol after total hip arthroplasty. Clin Orthop Relat Res2006;444:146–53.
110.
SarmientoAGoswamiAD. Thromboembolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty. J Bone Joint Surg Am1999;81:339–46.
111.
KakkosSKWarwickDNicolaidesANStansbyGPTsolakisIA. Combined (mechanical and pharmacological) modalities for the prevention of venous thromboembolism in joint replacement surgery. J Bone Joint Surg Br2012;94:729–34.
